Trading Report: The Zacks Investment Research Downgrades Landauer Inc. (LDR) to Hold

The Zacks Investment Research Downgrades Landauer Inc. (LDR) to Hold

Landauer Inc. (NYSE:LDR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “

Several other equities analysts have also recently weighed in on LDR. Hilliard Lyons cut shares of Landauer from a “neutral” rating to an “underperform” rating in a research note on Friday, July 1st. Sidoti cut shares of Landauer from a “buy” rating to a “neutral” rating and set a $52.00 target price for the company. in a research note on Tuesday, August 16th.

Landauer (NYSE:LDR) opened at 43.58 on Tuesday. The company has a market capitalization of $418.50 million, a P/E ratio of 23.56 and a beta of 1.08. Landauer has a 52 week low of $26.99 and a 52 week high of $49.74. The stock’s 50 day moving average is $45.38 and its 200 day moving average is $40.63.

Landauer (NYSE:LDR) last announced its quarterly earnings data on Monday, August 8th. The company reported $0.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.19. The firm had revenue of $37.90 million for the quarter, compared to the consensus estimate of $35.24 million. Landauer had a net margin of 11.63% and a return on equity of 102.93%. On average, equities research analysts expect that Landauer will post $1.76 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 5th. Shareholders of record on Friday, September 16th were paid a $0.275 dividend. The ex-dividend date of this dividend was Wednesday, September 14th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 2.52%. Landauer’s payout ratio is currently 59.14%.

Several institutional investors have recently modified their holdings of the company. Eqis Capital Management Inc. acquired a new position in shares of Landauer during the third quarter worth approximately $246,000. Schwab Charles Investment Management Inc. boosted its position in shares of Landauer by 1.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 31,279 shares of the company’s stock worth $1,288,000 after buying an additional 504 shares during the last quarter. Arizona State Retirement System acquired a new position in shares of Landauer during the second quarter worth approximately $204,000. Panagora Asset Management Inc. boosted its position in shares of Landauer by 56.4% in the second quarter. Panagora Asset Management Inc. now owns 9,391 shares of the company’s stock worth $386,000 after buying an additional 3,387 shares during the last quarter. Finally, Guggenheim Capital LLC boosted its position in shares of Landauer by 0.3% in the second quarter. Guggenheim Capital LLC now owns 8,815 shares of the company’s stock worth $363,000 after buying an additional 29 shares during the last quarter. 86.34% of the stock is owned by institutional investors and hedge funds.

Landauer Company Profile

Landauer, Inc (Landauer) is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a domestic provider of outsourced medical physics services and a provider of radiology related medical products. It operates in three business segments: Radiation Measurement, Medical Physics and Medical Products.

Related posts

Leave a Comment